Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 5Terminated 3Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 38Breast Neoplasms 38Lymphoma, Large B-Cell, Diffuse 35Multiple Myeloma 31Lymphoma, Non-Hodgkin 29Burkitt Lymphoma 29Lymphoma 27Myelodysplastic Syndromes 25Triple Negative Breast Neoplasms 23Recurrence 23Hematologic Neoplasms 22Lymphoma, B-Cell 21Lymphoma, Follicular 20Melanoma 16Ovarian Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Neoplasm Metastasis 14Leukemia 14Hodgkin Disease 13Neoplasms 12Leukemia, Biphenotypic, Acute 12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Pancreatic Neoplasms 11Neuroblastoma 11Leukemia, Myelomonocytic, Chronic 11Lymphoma, Mantle-Cell 10Graft vs Host Disease 10Carcinoma, Non-Small-Cell Lung 10Lymphoma, T-Cell, Peripheral 9

Interventions

Etoposide 27Carboplatin 26atezolizumab 16durvalumab 12Cisplatin 10Topotecan 9Drug Therapy 9PM 01183 7pembrolizumab 5Radiotherapy 5Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Irinotecan 4Injections 4Immunotherapy 4trilaciclib 3toripalimab 3Temozolomide 3Radiosurgery 3Bevacizumab 3AMG 757 3tislelizumab 2monalizumab 2irinotecan sucrosofate 2enzalutamide 2apatinib 2Platinum 2Nivolumab 2Itraconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Small Cell Lung Carcinoma × Cyclophosphamide × Clear all
NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

TCRCure Biopharma Ltd.

Phase EARLY_PHASE1 Recruiting
24 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡